002038.SZ Stock Analysis
00
Neutral
Based on Eyestock quantitative analysis, 002038.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Beijing SL Pharmaceutical Co., Ltd. engages in the development of new drugs. The company is headquartered in Beijing, Beijing and currently employs 761 full-time employees. The company went IPO on 2004-09-09. The firm's main products include complex coenzyme, arsenic trioxide, recombinant human granulocyte stimulating factor, recombinant human interleukin-2, recombinant human basic fibroblast growth factor, thymopentin, enoxaparin and Xingling dropping pills, among others. The firm distributes its products in domestic market and to overseas markets.